NVIDIA Corporation: Yorkville initiates coverage with an outperform rating; target price at $300
NVDA•Yorkville initiated coverage of NVIDIA with an outperform rating and a $300 target price.
Related News
Arvinas reports Phase 1 Parkinson’s trial data showing ARV-102-linked gains in oculomotor measure
ARVN•
Penguin Solutions Inc: Rosenblatt Securities raises target price to $100 from $80
PENG•
Zscaler, Inc.: Truist Securities raises target price to $250 from $200
ZS•
Kura Oncology-backed Caspian plans Phase 1 study of diabetes drug candidate KO-7246
KURA•
Lamb Weston Holdings: Wells Fargo raises target price to $58 from $54
LW•